You are here: Industry Insights > Gene Editing

News List

GenEdit reels in $8.5M to tackle delivery for gene therapy, gene editing fiercebiotech
December 27, 2018
In October last year, a team of UC Berkeley scientists reported a new, nonviral CRISPR-delivery system that might address safety concerns with the gene-editing technology.....
CRISPR controls obesity in mice by amplifying rather than editing genes fiercebiotech
December 26, 2018
The genes SIM1 and MC4R regulate food intake by signaling the feeling of being full, which is why mutations in those genes are associated with severe obesity.....
AZ and CRUK team up to go all-in on CRISPR pharmaphorum
December 11, 2018
AstraZeneca and Cancer Research UK are collaborating to launch a centre of excellence in genetic screening, cancer modelling and big data processing that will develop CRISPR technology to better understand the biology of cancer.
Intellia’s clinical head moves to CRISPR-focused Casebia to be its first CMO fiercebiotech
November 02, 2018
Intellia Therapeutics’ head of clinical development, Adel Nada, M.D., has left the gene-editing hopeful to serve as the first chief medical officer of Casebia Therapeutics, a joint venture launched by ...
This gene mutation is key to glioblastoma’s ‘immortality’ and could point to drug targets fiercebiotech
September 11, 2018
Glioblastoma, the brain cancer that took the life of Sen. John McCain, has proven especially difficult to target with drugs.
With promising data, ProQR Therapeutics' RNA-based eye drug heads to phase 3 fiercebiotech
September 06, 2018
ProQR’s treatment, QR-110, is designed to repair the genetic defect underlying LCA10 in the RNA, which could potentially stop disease progression or even reverse some of its effects.
CureGenetics secures $17 M in Series A Financing biospectrumasia
August 08, 2018
The company intends to use the proceeds to further optimize its gene editing and delivery platform.
Jennifer Doudna's new CRISPR company will tackle disease detection fiercebiotech
April 28, 2018
Mammoth Biosciences unveiled itself Thursday, with technology licensed from the lab of Jennifer Doudna, Ph.D., and a mission to develop a CRISPR-based platform ...
Horizon discovery launches multiplex I cfDNA reference standard set in synthetic plasma pharmaasia
March 09, 2017
Horizon Discovery Group plc, announces the launch of its first HDx cfDNA (cell-free DNA) reference standard in synthetic plasma.
US panel endorses human embryo gene editing, with caveats pharmafile
February 16, 2017
Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy of Sciences (NAS) and the National Academy of Medicine following an international committee in Washington, DC, but only in very specific circumsta

Previous page 1 2 Next page